Pfizers

FDA Considers Revoking Pfizer’s Covid Vaccine Approval for Under-5s: What This Means for Pediatric Health and Pharma Investors

FDA may pull authorization of Pfizer Covid shot for children under 5

Pfizer’s Covid-19 vaccine for healthy children under 5 is on the brink of losing FDA authorization—a development that could reshape pediatric vaccination strategies and ripple through the biotech and healthcare investment landscape. At Extreme Investor … Read more

Pfizer’s Q2 2025 Earnings Reveal Key Growth Drivers and Market Opportunities: What Investors Need to Know

Pfizer (PFE) Q2 2025 earnings report

Pfizer’s Latest Earnings Beat: What Investors Need to Know Beyond the Headlines Pfizer just delivered a second-quarter performance that not only surpassed Wall Street’s expectations but also raised its full-year adjusted profit guidance. While the … Read more